首页 | 本学科首页   官方微博 | 高级检索  
     


The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007–2012)
Authors:J.E. Tomlinson  E. Byrne  N. Pusterla  K. Gary Magdesian  H.G. Hilton  B. McGorum  E. Davis  A. Schoster  L. Arroyo  B. Dunkel  H. Carslake  R.C. Boston  A.L. Johnson
Affiliation:1. Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, PA;2. Alamo Pintado Equine Medical Center, Los Olivos, CA;3. Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA;4. Departments of Structural Biology and Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA;5. Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush, Midlothian, UK;6. Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS;7. Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Canada;8. Department of Clinical Science and Services, The Royal Veterinary College, North Mymms, Herts, UK;9. Philip Leverhulme Equine Hospital, University of Liverpool, Wirral, UK
Abstract:
Keywords:intrapleural  fibrinolysis  alteplase  pleuritis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号